Latest News

Pharmacists play a vital role in vaccine education and administration.

FDA accelerated approval speeds access but faces challenges with trial completion, costs, and end point validation.

Explore how the NCC MERP Severity Index transforms medication error reporting, enhancing safety and prevention strategies in healthcare systems.

As cellular and bispecific immunotherapies move into earlier treatment lines, pharmacists are interpreting new guidelines, managing toxicities, and shaping patient care strategies.

Environmental factors significantly influence the rising rates of type 2 diabetes in children.

The agency announced that human clinical trials will no longer be required in lieu of a comparative analytical assessment to determine biosimilar equivalency with its reference product.

Liposomal vitamin C enhances bioavailability, offering superior absorption and antioxidant benefits compared with traditional forms, promising better health outcomes.

Heavy workloads, lack of recognition, and stressful environments fuel emotional exhaustion, turnover, and patient safety concerns.

COVID-19 mRNA vaccines enhance immune checkpoint inhibitor effectiveness in cancer therapy, significantly improving survival rates for patients with advanced tumors.

Missteps in prescribing and counseling can escalate into catastrophic harm and significant financial liability.

Recent research reveals rising cancer rates among younger and older adults, linking obesity to increased incidence.

Pharmacist Care Day showcased UPMC Health Plan’s commitment to whole-person care through free health services, pharmacist-led outreach, and strong community collaborations in Pittsburgh.

Christina Barrington, PharmD, champions pharmacists' vital role in enhancing health care access and quality, advocating for their recognition as essential providers.

In Danish athletes, long-term anabolic androgenic steroid use was associated with progressively worsened cardiovascular outcomes.

The FDA approves a simplified single-injection treatment for ulcerative colitis, enhancing patient experience with monthly dosing convenience.

A new low-carbon albuterol inhaler shows therapeutic equivalence to original options, suggesting reduced emissions and improved sustainability for patients with asthma and other respiratory conditions.

Oncologists increasingly embrace cell and gene therapies, yet barriers like cost and perceptions of risk hinder broader adoption.

Total cholesterol and triglyceride levels were linked to an increased risk of Alzheimer-related declines in cognitive function, whereas high-density lipoprotein cholesterol provided a protective effect.

Expert shares notable findings presented at the 2025 IMS Annual Meeting.

Lawmakers weigh cost concerns, clinical outcomes, and regulatory barriers as access to these medications evolves.

Explore the impact of extrapyramidal symptoms on patients, including drug-induced parkinsonism and dystonia, and the importance of early detection and management.